Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Prothrombin Complex Concentrates Market Research Report 2019-2025

Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Prothrombin Complex Concentrates Industry
  • 1.7 COVID-19 Impact: Prothrombin Complex Concentrates Market Trends
  • 2 Global Prothrombin Complex Concentrates Quarterly Market Size Analysis

    • 2.1 Prothrombin Complex Concentrates Business Impact Assessment - COVID-19
      • 2.1.1 Global Prothrombin Complex Concentrates Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Prothrombin Complex Concentrates Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Prothrombin Complex Concentrates Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Prothrombin Complex Concentrates Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Prothrombin Complex Concentrates Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Prothrombin Complex Concentrates Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Prothrombin Complex Concentrates Market
    • 3.5 Key Manufacturers Prothrombin Complex Concentrates Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Prothrombin Complex Concentrates Segments, By Type

    • 4.1 Introduction
      • 1.4.1 3F Prothrombin Complex Concentrates
      • 1.4.2 4F Prothrombin Complex Concentrates
    • 4.2 By Type, Global Prothrombin Complex Concentrates Market Size, 2019-2021
      • 4.2.1 By Type, Global Prothrombin Complex Concentrates Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Prothrombin Complex Concentrates Price, 2020-2021

    5 Impact of Covid-19 on Prothrombin Complex Concentrates Segments, By Application

    • 5.1 Overview
      • 5.5.1 Compound Pharmacies
      • 5.5.2 Hospital Pharmacies
      • 5.5.3 Retail Pharmacies
    • 5.2 By Application, Global Prothrombin Complex Concentrates Market Size, 2019-2021
      • 5.2.1 By Application, Global Prothrombin Complex Concentrates Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Prothrombin Complex Concentrates Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Takeda
      • 7.1.1 Takeda Business Overview
      • 7.1.2 Takeda Prothrombin Complex Concentrates Quarterly Production and Revenue, 2020
      • 7.1.3 Takeda Prothrombin Complex Concentrates Product Introduction
      • 7.1.4 Takeda Response to COVID-19 and Related Developments
    • 7.2 Octapharma AG
      • 7.2.1 Octapharma AG Business Overview
      • 7.2.2 Octapharma AG Prothrombin Complex Concentrates Quarterly Production and Revenue, 2020
      • 7.2.3 Octapharma AG Prothrombin Complex Concentrates Product Introduction
      • 7.2.4 Octapharma AG Response to COVID-19 and Related Developments
    • 7.3 Nihon Pharmaceutical
      • 7.3.1 Nihon Pharmaceutical Business Overview
      • 7.3.2 Nihon Pharmaceutical Prothrombin Complex Concentrates Quarterly Production and Revenue, 2020
      • 7.3.3 Nihon Pharmaceutical Prothrombin Complex Concentrates Product Introduction
      • 7.3.4 Nihon Pharmaceutical Response to COVID-19 and Related Developments
    • 7.4 Sanquin Blood Supply Foundation
      • 7.4.1 Sanquin Blood Supply Foundation Business Overview
      • 7.4.2 Sanquin Blood Supply Foundation Prothrombin Complex Concentrates Quarterly Production and Revenue, 2020
      • 7.4.3 Sanquin Blood Supply Foundation Prothrombin Complex Concentrates Product Introduction
      • 7.4.4 Sanquin Blood Supply Foundation Response to COVID-19 and Related Developments
    • 7.5 CSL Behring GmbH
      • 7.5.1 CSL Behring GmbH Business Overview
      • 7.5.2 CSL Behring GmbH Prothrombin Complex Concentrates Quarterly Production and Revenue, 2020
      • 7.5.3 CSL Behring GmbH Prothrombin Complex Concentrates Product Introduction
      • 7.5.4 CSL Behring GmbH Response to COVID-19 and Related Developments
    • 7.6 Grifols
      • 7.6.1 Grifols Business Overview
      • 7.6.2 Grifols Prothrombin Complex Concentrates Quarterly Production and Revenue, 2020
      • 7.6.3 Grifols Prothrombin Complex Concentrates Product Introduction
      • 7.6.4 Grifols Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Prothrombin Complex Concentrates Supply Chain Analysis
      • 8.1.1 Prothrombin Complex Concentrates Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Prothrombin Complex Concentrates Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Prothrombin Complex Concentrates Distribution Channels
      • 8.2.2 Covid-19 Impact on Prothrombin Complex Concentrates Distribution Channels
      • 8.2.3 Prothrombin Complex Concentrates Distributors
    • 8.3 Prothrombin Complex Concentrates Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Prothrombin Complex Concentrates, including the following market information:
      Global Prothrombin Complex Concentrates Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Prothrombin Complex Concentrates Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Prothrombin Complex Concentrates Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Prothrombin Complex Concentrates Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

      Key market players
      Major competitors identified in this market include Takeda, Octapharma AG, Nihon Pharmaceutical, Sanquin Blood Supply Foundation, CSL Behring GmbH, Grifols, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      3F Prothrombin Complex Concentrates
      4F Prothrombin Complex Concentrates

      Based on the Application:
      Compound Pharmacies
      Hospital Pharmacies
      Retail Pharmacies

      Buy now